Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can lipitor negatively interact with other liver affecting medications?Can high iron plants impact lipitor's effectiveness?How does lipitor affect wine's taste?How much can lipitor card save me?Can you provide a timeline for teflaro's generic release?
See the DrugPatentWatch profile for vascepa
What drugs interact with Vascepa? Vascepa (icosapent ethyl) is an omega-3 fatty acid prescription drug used to lower triglyceride levels and reduce cardiovascular risk in certain patients. Its main interactions occur with anticoagulants and antiplatelet agents because it can increase bleeding risk. Anticoagulants and antiplatelet drugs Warfarin, aspirin, clopidogrel, and heparin can interact with Vascepa. Patients taking these medications may experience prolonged bleeding times. Regular INR monitoring is recommended when Vascepa is added to warfarin therapy. Other omega-3 supplements Fish oil, krill oil, or other over-the-counter omega-3 products can add to the triglyceride-lowering effect and bleeding risk. Combining them with Vascepa is usually discouraged unless a doctor specifically directs it. Statins and fibrates No major pharmacokinetic interactions occur with atorvastatin, rosuvastatin, or fenofibrate. Clinical studies showed that adding Vascepa to statin therapy did not alter statin blood levels, but patients should still be monitored for additive side effects such as muscle pain. How long do interactions last after stopping Vascepa? The drug is eliminated slowly; effects on bleeding time can persist for several days after the last dose. Patients scheduled for surgery are often advised to stop Vascepa at least one week beforehand. Can I take Vascepa with blood pressure medications? Vascepa does not significantly interact with common antihypertensives such as ACE inhibitors, ARBs, or beta-blockers. Blood pressure readings remain stable in most patients taking both drug classes. When does the Vascepa patent expire? The key U.S. patent covering icosapent ethyl is set to expire in 2030, with possible extensions. After expiry, generic versions may enter the market and could affect pricing and availability. Who makes Vascepa? Amarin Pharmaceuticals holds the rights to Vascepa. The company markets the drug in the United States and several other countries. Are there cheaper alternatives to Vascepa? Over-the-counter fish oil is less expensive but lacks the purified EPA-only formulation and cardiovascular-outcome data that Vascepa carries. Prescription alternatives such as Lovaza (omega-3-acid ethyl esters) contain both EPA and DHA and may be covered differently by insurance. [1] https://www.drugpatentwatch.com/drug/icosapent-ethyl
Other Questions About Vascepa :